International Journal of Molecular and Immuno Oncology (IJMIO) is a peer-reviewed journal where clinicians and researchers can contribute and keep up with the fast-paced developments in Molecular Biology and Immuno oncology.The journal is owned by the Alms Tech LLP and published by Scientific Scholar(https://scientificscholar.com/)
20000 people have visited the journal website in the last one year at https://ijmio.com/
In 2021 we received 28 manuscripts, of which 19 were accepted after rigorous peer -review and then published.
To date, we have had 591,992 full-text manuscript downloads from our journal website.
The most viewed manuscript is Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Year: 2021, Volume: 6, Issue: 1, January-April DOI:10.25259/IJMIO_30_2020
